CELL-DYN Emerald Cleaner / CELL-DYN Emerald Cleaner Registration Number ANVISA: 80146501650 ### Hazard Class: I (PRODUCTS OF LOW RISK TO INDIVIDUAL AND LOW RISK TO PUBLIC HEALTH, SUBJECT TO REGISTRATION) ### Lot : 7044 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Abbott Laboratórios do Brasil; Abbott Laboratories Diagnostics Division. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1974
  • 날짜
    2016-08-25
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    Recommendations to Users and Patients: If you HAVE an alternative lot of Emerald Cleaner available in stock (except 6853, 6901, 6953, 6991, 7024 or 7027), immediately discontinue use of impacted lots of Emerald Cleaner. 1. Start using the alternative lot of Emerald Cleaner. 2. Perform the Decontamination Procedure in accordance with the CELL-DYN Emerald Operations Manual (9140859 version H), pages 9-16, steps 1 -3. (See Appendix 1.) This will take 15 to 30 minutes. 3. Check QC and follow any additional laboratory procedures. Return the remaining stock of the impacted batches of Emerald Cleaner according to your laboratory procedures. If you do not have an alternative batch available and you are not observing QC outside the low range for RBC and PLT parameters, immediately request a replacement lot from Emerald Cleaner. Make sure you meet your internal QC requirements. You can continue to use the batch until the replenishment arrives. After you receive the replacement batch, follow steps 1-3: 1. Begin using the alternative batch of Emerald Cleaner. 2. Perform the Decontamination Procedure in accordance with the CELL-DYN Emerald Operations Manual (9140859 version H), pages 9-16, steps 1-3. (See Appendix 1.) This will take 15 to 30 minutes. 3. Check QC and follow any additional laboratory procedures. Please return the remaining stock from lots 7044, 7082, 7110 or 7119 according to your laboratory procedures. If you wish to notify technical complaints and adverse events use the following channels: Notivisa: Notices of adverse events (AE) and technical complaints (QT) for products subject to Sanitary Surveillance should be made through the NOTIVISA System. To access the System, you must register and select the Health Professional option, if you are a liberal professional or the Institution / Entity option, if you are a professional of an institution / entity. Technovigilance System: Patient or citizen can notify through the Technovigilance System / SISTEC access through the link
  • 원인
    Abbott has previously identified occurrences where the cell-dyn emerald analyzer generated out-of-range qc results for the rbc and plt parameters when using emerald cleaner lots 6853, 6901, 6953, 6991, 7024, and 7027 tests with lots 7044, 7082, 7110, and 7119 confirmed the out-of-range rbc and plt controls. the cause of the problem (qc material outside the low range) has been identified in the manufacturing process of a raw material used in the cell-dyn emerald cleaner.
  • 조치
    Field Action FA24MAR2016 - Revision 02 triggered under the responsibility of Abbott Laboratories of Brazil. Gathering for Destruction

Manufacturer

  • 제조사 모회사 (2017)
  • 제조사 의견
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    ANVSANVISA